DENGUE INFECTION 1ST ENCOUNTER CPG Mx of Dengue Infection Revised 2 nd Edition, 2010 Mohd Ghazali AR, 21th November 2012.

Slides:



Advertisements
Similar presentations
Emergency Care Part 1: Managing Diabetic Ketoacidosis (DKA)
Advertisements

LESSON 16 BLEEDING AND SHOCK.
SEPSIS KILLS program Paediatric Inpatients
The ACOG Task force on hypertension in pregnancy
Flight Surgeon RSV Day I n t e g r i t y - S e r v i c e - E x c e l l e n c e ANGRC Joint Base Andrews UNCLASSIFIED.
Development Committee
Chapter 6 Fever Case I.
2 Module 1 Pathophysiology Clinical course WHO classification & limitation Other manifestations Dr Suresh Kumar Infectious Diseases Unit Hospital Sungai.
III. Clinical Manifestations of Dengue and Dengue Hemorrhagic Fever CENTERS FOR DISEASE CONTROL AND PREVENTION.
SEPSIS KILLS program Adult Inpatients
Recognition and management of the seriously ill child Dr Esyld Watson Consultant in Adult and Paediatric Emergency Medicine.
Abdominal pain complicated 3 rd trimester pregnancy AUTHOR DR. PAULIN NG REVISED BY DR. WONG HO TUNG OCT, 2013 HKCEM College Tutorial.
Dengue Divya Bappanad Karapitya Hospital Galle, Sri Lanka.
Management of Dengue Fever Dr David Tran 16/09/09.
Mr MZ. History 32 years old man Fever for 4 days Myalgia, arthralgia Headache Poor oral intake Vomiting.
CASE PRESENTATION - 4. Day 3 onset of fever, 0730am C/O: Fever-3 days Nausea and vomiting Myalgia. O/E Comfortable Pulse 98/min BP= 98/60mmHg T=37.5 Lungs.
Severe Sepsis Initial recognition and resuscitation
Dengue Virus Causes dengue and dengue hemorrhagic fever
Illinois EMSC1 Upon completion of this lecture, you will be better able to: n Define shock n Describe key differences between the pediatric and adult circulatory.
Bleeding and Shock CHAPTER 25 1.
Case Study: Dengue Virus Virology 516 Fall 2007 Milette Mahinan, Suzi Sanchez, Olayinka Taiwo.
3. Documentation and Monitoring of Dengue Patients
Management of Severe Dengue
DENGUE EPIDEMIOLOGY AND CONTROL PROGRAM IN MALAYSIA
Dr. Paramita Sengupta Department Of Community Medicine Christian Medical College Ludhiana Co-authors: Ragini Mann, Rohit Theodore, A I Benjamin Risk factors.
Dengue fever Febrile phase 2-7 DAYS Convalescent phase 2-5 DAYS Longer in adults 1.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
Shock.
What Type of Shock is This?
Andrea Montelibano Isabelle Escobillo. The Virus Flavivirus Single strand RNA 4 serotypes – DENV-1 – DENV-2 – DENV-3 – DENV-4 Infection with one serotype.
Embryo development Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6.
OVERVIEW OF DENGUE AND ITS MANAGEMENT Dr
1 Early Recognition of the Deteriorating Patient A guide for health care providers.
Chapter 32 Shock Copyright (c) The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Patient Assessment during Influenza Epidemics Patient Assessment during Influenza Epidemics An Outline of the Approach to Patients An Outline of the Approach.
D NGUE WORKSHOP 2015 ID HSB OPD – CASE 4 ID HSB 2015.
W HAT ` S N EW IN DHF: C LINICAL ASPECT Professor Siripen Kalayanarooj, Director, WHO Collaborating Centre for Case Management of Dengue/DHF/DSS, Queen.
D NGUE WORKSHOP 2015 ID HSB OPD – CASE 3 ID HSB 2015.
E D NGUE WORKSHOP 2015 CHALLENGES IN THE MANAGEMENT OF DENGUE
Life Support in Haemorrhage and Fluid Loss H.Gee MD, FRCOG.
Clinical Presentation of DHF. Dengue should be considered in the differential diagnosis of febrile patients with a history of travel to the tropics in.
Dengue ..
D NGUE WORKSHOP 2015 E ID HSB 2015.
PROF. DR. MUHAMMAD YAQUB KAZI MBBS, MCPS (Family Medicine) DCH (Pb), MCPS (Paeds), FCPS (Paeds), FRCP (Edin), FRCP (London), FRCPCH (UK) Ex Dean, Institute.
VII. Treatment. Outpatient Triage n No hemorrhagic manifestations and patient is well-hydrated: home treatment n Hemorrhagic manifestations or hydration.
Tropical Fevers Case 1: 27 year old woman comes to a local health unit with history of a gradual onset of fever and headache and loss of appetite over.
28/02/2011 N-PICU Mahosot Hospital SOUMPHONPHAKDY Bandith. SCENARIO CASE 1.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
PHILHEALTH CLINICAL PATHWAYS CLINICAL GUIDELINES.
D NGUE WORKSHOP 2015 ID HSB OPD – CASE 5 ID HSB 2015.
Limmer, First Responder: A Skills Approach, 7th ed. © 2007 by Pearson Education, Inc. Upper Saddle River, NJ Chapter 18 Bleeding and Shock.
Warning Signs Y es No Unk Persistent Vomiting…………..... Abdominal pain/Tenderness.. Mucosal Bleeding …………….. Lethargy, restlessness……….… Liver Enlargement.
Bacterial meningitis and meningococcal septicaemia Implementing NICE guidance June 2010 NICE clinical guideline 102.
Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.
PROSPECTIVE COHORT STUDY OF ACUTE PYELONEPHRITIS IN ADULTS: SAFETY OF TRIAGE TOWARDS HOME BASED ORAL ANTIMICROBIAL TREATMENT C. VAN NIEUWKOOP A,*, J.W.
DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R Tel. (787) ,
Early Recognition of the Deteriorating Patient
DENGUE FEVER Prof. Dr. Muhammad Ali Khan MBBS, DCH, MRCP (UK)
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated May 26, 2017.
Internal Medicine Workshop Series Laos September /October 2009
Dr.Humra nasim PGT-Medicine HFH,RWP
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
CALS Instructor Update July 14, 2016
Sepsis Surgeon Champions Talking Points
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Respiratory Therapists & Sepsis: How we can work together
Competency Title : Observations and The Deteriorating Patient for HCAs Competency Lead : Vikki Crickmore, Sister, Critical Care Outreach Team September.
Calculate Well’s score for PE (BOX1)
Chapter 6 Fever Case I.
Chapter 4 Cough or difficult breathing Case I
Presentation transcript:

DENGUE INFECTION 1ST ENCOUNTER CPG Mx of Dengue Infection Revised 2 nd Edition, 2010 Mohd Ghazali AR, 21th November 2012

These are Clinical Practice Guidelines on Management of Dengue Infection in Adults (Revised 2nd Edition) The CPG supersede the previous CPG on Management of Dengue Infection in Adults (2nd Edition) Review of the Guidelines These guidelines were issued in 2010 and will be reviewed in 2014 or sooner if new evidence becomes available.

Clinical Course 1.Febrile Phase 2.Critical Phase 3.Recovery Phase

Febrile Phase Sudden High Grade Fever Skin erythema Generalised body ache – Myalgia, Arthralgia, Headache Sore Throat, Conjunctival injection Anorexia, Nausea, Vomiting *Indistinguishable between DF, DHF, Other viral diseases

Febrile Phase (Cont…) Mild Hemorrhagic Manifestations – Petechiae – Epistaxis – Gum bleeding – May be seen in both DF & DHF Mild PV bleeding is common in young adult Females Enlarged tender liver suggestive of DHF

Febrile Phase (Cont…) The earliest abnormality of FBC is Progressive decrease total white cell count *Alert & Notify as early as possible to avoid epidemic

Differential Diagnoses During Febrile Phase

Critical Phase After 3 rd day of fever – Defervescence Period Rapid drop in temperature Patient may become – Better: if minimal plasma leakage – Worse: if critical plasma volume lost Lasted hours Between 3 rd -7 th day of illness * Other viral infections: Condition improves as temperature subsides

Critical Phase (cont…) Less severe cases – Minimal & Transient – Recover after short period of fluid therapy Severe form (Sign of Shock) – Restless, Altered conscoius level – Sweating, Cool extermity – Prolong capillary refill time – PR increases, Narrow Pulse pressure (DBP increases) – Clinical fluid accumulation

Critical Phase (cont…) Thrombocytopenia & Hemoconcentration – usually detectable before fever subside & onset of shock Hematocrit level correlates with plasma volume loss Hematocrete may be equivocal in – Early fluid therapy – Excessive fluid therapy – Frank HEMORRHAGE

Differential Diagnosis During Critical Phase

Common Errors at ED & OPD Failure to recognise dengue infection in a febrile patient: No f/up * Always have high index of suspicion in patients with symptoms of viral infection febrile patients coming from dengue areas patients with positive Hess’s test Failure to recognise dengue shock in an afebrile patient: Not Admitted * Always have high index of suspicion for Nausea, vomiting, abdominal pain & WARNING SIGNS Clinical manifestations of Shock Changing HCT (rather than platelet count)

WARNING SIGNS Sign of SEVERE DENGUE & high possibility of RAPID PROGRESSION TO SHOCK 1.Persistent vomiting 2.Abdominal pain or tenderness 3.Mucosal bleed 4.Restlessness or lethargy 5.Clinical fluid accumulation (pleural effusion, ascites) 6.Liver enlargement > 2 cm 7.Laboratory : Increase in HCT with rapid decrease in platelet

Patients Who Can be Treated at Home Able to tolerate orally well, good urine output and no history of bleeding Haemodynamically stable No tachypnoea or acidotic breathing No bleeding manifestation No alterations in mental state and full GCS score Absence of clinical Warning Signs Stable serial HCT In the absence of a baseline HCT level, a HCT value of >40% in FEMALE adults and >46% in MALE adults should raise the suspicion of plasma leakage.

Daily or more frequently towards late febrile phase

Home Care ADVICE LEAFLET for Dengue Patient

Home Care Advice Leaflet for Dengue Patient

Critical Phase Crutial to diagnose – Clinical deterioration Marked by plasma leakage at the onset of defervescence Evidence by – Raised HCT – Hemodynamic instability – Late marker: Fluid in extravascular space Warning sign!!!...

The indicator of hemorrhagic tendency Sensitivity varies widely – 0% - 57% – Depends on phase of illness, how often it is repeated 5-21% of dengue like illness have positive torniquet test but negative for dengue serology 95.3% positive preditive value when fever, positive tourniquet, leucopenia / thrombocytopenia / hemoconcentration are present Tourniquet Test

How to perform? Inflate the BP cuff on the upper arm to a point midway between the SBP & DBP for 5 minutes A positive test : ≥20 petechiae per 2.5 cm 2 (1 inch 2 ) Helpful in the early febrile phase (< 3 days) esp. -When the platelet count is still -When diagnosis is in doubt

Triaging at ED & OPD To avoid to avoid critically ill patients being missed & managed as outpatient To determine the need of urgent attention/resus  Primary Triage  Sign of Shock (Mental state, Cold or warm peripheries, Palor, Delayed Capillary perfusion)  Vital Parameters (BP, PR, Temperature, RR)  Warning signs!!!

Criteria for Admission Symptoms: 1. Warning signs 2. Bleeding manifestations 3. Inability to tolerate oral fluids 4. Reduced urine output 5. Seizure Signs: 1. Dehydration 2. Shock 3. Bleeding 4. Any organ failure Lab. criteria Rising HCT with reducing platelet count

Consider Early Admission Co-morbidity DM, HPT, IHD, Coagulopathies, Morbid Obesity, Renal failure, Chronic Liver disease, COPD Elderly (> 65 y/o) Pregnancy Social factors: living far, living alone, no transport etc.

Prerequisites for transfer All efforts must be taken to optimise the patient’s condition before and during transfer The Medical Department and/or Emergency Department must be informed prior to transfer Adequate and essential information must be sent together with the patients (fluid chart, monitoring chart and investigation results)

Initial Fluid Resuscitation Crystalloid – Normal Saline – ml/kg ideal body wt – Repeat x2 Consider Colloid 3 rd cycle Other causes of persistent shock – OCCULT BLEEDING – Septic – Cardiogenic IDEAL BODY WEIGHT Male: 50.0kg (height-152.4)cm Female: 45.5kg (height-152.4)cm

Blood Product Suspect occult bleeding if HCT drops and no obvious bleeding – Fresh Packed Cell 5-10 ml/kg – Fresh Whole Blood ml/kg Repeat – Further blood loss – No appropriate raise of HCT Prophylactic transfusion? Fresh Blood: < 5 days

DSS Compensated shock Decompensated shock

CVC line Thrombocytopenia & Bleeding diathesis are relative contraindication – No studies regarding bleeding risk in dengue patient – Incidence of bleeding in coagulopathy patients varies (0-15.5%) Fluid resuscitation does not require CVC if sufficient peripheral access When indicated – Should be inserted by skilled operator preferably under USG guidance – Avoid Subclavian site

ICU referral & Respiratory Support Indications for ICU referral Emergency Intubation Elective intubation – Main objectives is to support gas exchange & reduce metabolic cost of breathing

Haemodynamic Support FLUID RESUSCITATION IS CRUCIAL !!! Should be initiated first & adequately Vasopressor may be consider if MAP persistently <60mmHg despite adequate resuscitation (dopamine, noradrenaline) * While vasopressor increase BP, tissue hypoxia may be further compromised by vasoconstriction

Dengue In Pregnancy All Pregnant women suspected dengue – ADMIT Diagnosis & Assessment Challenges – Baseline HR is higher – Baseline blood pressure is lower (pulse pressure are wider) – HCT elevation may be masked haemodilution in 2 nd & 3 rd trimester – Detection of third space loss is difficult with gravid uterus

Dengue In Pregnancy (Cont…) Risk of bleeding is highest during period of plasma leakage – Avoid IOL during critical phase – Avoid manoeuvres that may provoke labour during critical phase Differential Diagnosis – Toxemia – HELLP Syndrome

Disease Notification All suspected dengue must be notified by telephone to nearest health office within 24 hours of diagnosis Serological confirmation is NOT NECESSARY Notified cases will be followed up by the health authorities for the verification disease and preventive measures Re-notification has to be done if the diagnosis has been changed from DF to DHF or DF to other diagnosis.

Failure to notify is liable to be compounded under the Prevention and Control of Infectious Diseases Act, 1988 (Act 342)

Summary Stepwise Approach on Outpatient Management of Dengue Infection (Pg-17)

Thanks For the attention Question?